DOI: 10.25881/20728255_2026_21_4_S1_63

Authors

Petrachkov D.V. , Filippov V.M., Urusova E.A.

Krasnov Research Institute of Eye Diseases, Moscow

Abstract

Diabetic maculopathy (DM) is a complication of diabetes mellitus and one of the leading causes of blindness and visual impairment among the working-age population. In cases of DM requiring vitreoretinal surgery, there is no consensus regarding the necessity of the internal limiting membrane (ILM) peeling. Questions remain concerning the causes of suboptimal treatment outcomes and strategies for preventing complications.

Objective. To evaluate the incidence, occurrence and impact of transient intraoperative tractions (TIT) which may arise during ILM peeling in vitrectomy for DM, on the anatomical and functional outcomes of treatment.

Material and Methods. A retrospective cohort study was conducted on 56 cases (56 eyes) involving vitrectomy with ILM peeling for the DM treatment. The incidence of TIT and its influence on anatomical and functional outcomes were assessed. The study groups categorized by the presence or absence of TIT were comparable in their baseline characteristics.

Results. TIT was identified as an unfavorable prognostic factor, associated with lower postoperative visual acuity. In cases where TIT occurred, patients were more likely to develop long-term neurodegenerative complications, such as atrophy of the inner retinal layers and the formation of degenerative lamellar macular holes.

Conclusion. TIT is an independent but modifiable risk factor associated with the ILM peeling procedure during vitreoretinal DM surgery which is significantly affecting both anatomical and functional treatment outcomes.

Keywords: diabetic retinopathy (DR), diabetic maculopathy (DM), internal limiting membrane (ILM), transient intraoperative tractions (TIT).

References

1. Dedov I, Shestakova M, Sukhareva O, et al. Standards of Specialized Diabetes Care. 12th Edition. Diabetes mellitus. 2025; 28(5S): 1-175. (In Russ.) doi: 10.14341/DM20255S.

2. Chekhonin ES, Fayzrakhmanov RR, Sukhanova AV, Bosov ED. Anti-VEGF therapy for diabetic retinopathy. Russian Annals of Ophthalmology. 2021; 137(4): 136-142. (In Russ.) doi: 10.17116/oftalma2021137041136.

3. Fayzrakhmanov RR, Petrachkov DV, Pavlovskiy OA, et al. Diabetic retinopathy and diabetic macular edema: etiopathogenesis and vitreoretinal surgery as one of the methods of treatment. Russian Annals of Ophthalmology. 2026; 142(2): 86-91. (In Russ.) doi: 10.17116/oftalma202614202186.

4. Rinaldi M, dell’Omo R, Morescalchi F, et al. ILM peeling in nontractional diabetic macular edema: review and metanalysis. Int Ophthalmol. 2018; 38(6): 2709-2714. doi: 10.1007/s10792-017-0761-6.

5. Chung YR, Lee E, Kim H, et al. Efficacy of Internal Limiting Membrane Peeling in Eyes with Proliferative Diabetic Retinopathy: A Meta-Analysis. Ophthalmologica. 2025; 248(5-6): 386-400. doi: 10.1159/000547416.

6. Nakajima T, Roggia MF, Noda Y, Ueta T. Effect of internal limiting membrane peeling during vitrectomy for diabetic macular edema: Systematic Review and Meta-analysis. Retina. 2015; 35(9): 1719-25. doi: 10.1097/IAE.0000000000000622.

7. Kumagai K, Hangai M, Ogino N, Larson E. Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema. Retina. 2015; 35(7): 1422-8. doi: 10.1097/IAE.0000000000000497.

8. Romano MR, Cennamo G, Schiemer S, et al. Deep and superficial OCT angiography changes after macular peeling: idiopathic vs diabetic epiretinal membranes. Graefes Arch Clin Exp Ophthalmol. 2017; 255(4): 681-689. doi: 10.1007/s00417-016-3534-4.

9. Akino K, Nagai N, Watanabe K, et al. Risk of newly developing visual field defect and neurodegeneration after pars plana vitrectomy for idiopathic epiretinal membrane. Br J Ophthalmol. 2021; 105(12): 1683-1687. doi: 10.1136/bjophthalmol-2020-317478.

10. Gunay BO, Erdogan G. Evaluation of Macular Changes in the Long Term after Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Diabetic Macular Edema. Ophthalmologica. 2021; 244(3): 237-244. doi: 10.1159/000514992.

11. Bringmann A, Pannicke T, Grosche J, et al. Müller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006; 25(4): 397-424. doi: 10.1016/j.preteyeres.2006.05.003.

12. Matsunaga N, Ozeki H, Hirabayashi Y, et al. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina. 2005; 25(3): 311-6. doi: 10.1097/00006982-200504000-00010.

13. Stolyarenko GE, Kolchin AA, Didenko LV, et al. A porous coral-like structure — a new insight into the morphology of the inner limiting membrane of the retina? Russian Annals of Ophthalmology. 2016; 132(6): 70-77. (In Russ.) doi: 10.17116/oftalma2016132670-77.

For citation

Petrachkov D.V. , Filippov V.M., Urusova E.A. Assessing the role of the mechanical factor in the diabetic maculopathy surgical treatment. Bulletin of Pirogov National Medical & Surgical Center. 2026;21(4,supplement):63-67. (In Russ.) https://doi.org/10.25881/20728255_2026_21_4_S1_63